Definium Therapeutics (DFTX) Goodwill & Intangibles (2020 - 2026)

Definium Therapeutics (DFTX) has 7 years of Goodwill & Intangibles data on file, last reported at $19.9 million in Q1 2026.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $19.9 million, changed 0.0% from the prior year.
• Goodwill & Intangibles held at $19.9 million in Q1 2026 per DFTX's latest filing, from $19.9 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $26.0 million in Q1 2022 and bottomed at $19.9 million in Q1 2024.
• The 5-year median for Goodwill & Intangibles is $19.9 million (2024), against an average of $21.5 million.
• The widest annual swing landed in 2022, when Goodwill & Intangibles dropped 28.5%; it then changed 0.0% in 2025.
• Tracing DFTX's Goodwill & Intangibles over 5 years: stood at $23.6 million in 2022, then slipped by 13.39% to $20.4 million in 2023, then slipped by 2.58% to $19.9 million in 2024, then changed by 0.0% to $19.9 million in 2025, then changed by 0.0% to $19.9 million in 2026.
• Per Business Quant, the three latest DFTX Goodwill & Intangibles figures stand at $19.9 million (Q1 2026), $19.9 million (Q4 2025), and $19.9 million (Q3 2025).

Peer Comparison